BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech

LISCure Biosciences announces research collaboration with Mayo Clinic for rare liver diseases

LISCure has been conducting joint research with Mayo Clinic for NASH drugs since 2021, and this new collaboration is an agreement signed under the leadersh...

January 07, 2022 | News

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The deal will i...

January 07, 2022 | News

Illumina Enters Co-Development Partnership with SomaLogic

Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Prot...

January 06, 2022 | News

GC Cell seeks to expand global availability of Immuncell-LC® for liver cancer

Rivaara Immune to lead development and commercialization in India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they hav...

January 05, 2022 | News

Alamar Biosciences partners with Abcam to drive understanding of the human proteome

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and othe...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

January 03, 2022 | News

Clarivate Acquires Patient Connect To Provide Patient-Centric Solutions

 Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it...

December 23, 2021 | News

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster

Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...

December 23, 2021 | News

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Cladrib...

December 22, 2021 | News

BeiGene expands commercial portfolio in China

Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...

December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

December 20, 2021 | News

Sartorius and HOF Sonderanlagenbau Partnership Creates Streamlined Offering of Freeze-Thaw Solutions for Biological Products

Compatible equipment and consumables will allow for quick and streamlined validation of freeze-thaw solutions for customers along with easier purchase an...

December 16, 2021 | News

Stay Connected